#Product Trends
The Third Generation Laser Speckle Imaging System RFLSI-ZW is Coming Out Soon
RWD new product will be released soon.
RWD will launch the third-generation Laser Speckle Imaging System (RFLSI-ZW) in 2022, maintaining its continuous influence and supporting role in the field of microcirculation research.
The eye-catching upgrades of the third-generation RFLSI-ZW include:
Highlight 1: The TR-LSCI technology laser transmission module is built into the product. Not only are the imaging contrast and detection depth better, but the testing of vascular functional information is also supported.
Highlight 2: The change indicators for oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb) can be tested as never before.
Highlight 3: The expanded detection area makes the experience of power zoom and auto focus better.
Compared with RFLSI Ⅲ, the detection area of RFLSI-ZW has been increased by more than 8 times.
Unexampled Advantages of TR-LSCI Technology Laser Transmission Module
For traditional LSCI technology, light must penetrate the tissue layers (e.g., skin & skull) above blood vessels, where the light signal would be continuously attenuated. With better imaging contrast and resolution than conventional LSCI, Transmission detection laser speckle contrast imaging (TR-LSCI) can even support functional imaging of human finger joints in the absence of other complementary means.
